CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-14). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2517 · Search date 2026-08-14 · Methodology v0.7

Yellow night-driving glasses,
does it really help with Faster pedestrian detection under headlight glare?

30-Second Summary
D
Evidence Grade D · 30 · Safety caution
Yellow lenses attenuated blue-range light but did not improve pedestrian response time in a night-driving simulator.
Tinted lenses reduce the amount of light reaching the eye at night. Persistent blur, glare, or poor night vision should prompt assessment for refractive error, cataract, or other causes rather than reliance on tinted driving glasses.
What the
research shows
The grade is D. In a 22-person night-driving simulator experiment where each participant used three commercial yellow lenses and a clear lens, the overall lens main effect was F(1,63)=0.64, P=.42. Yellow lenses did not shorten response time in any condition. Public funding is reflected in D with 30 points.
What the
ads claim
Measured attenuation of short-wavelength light cannot be rewritten as evidence that drivers see people sooner. Passing less light and improving night-detection performance are different claims.
*

Useful facts when choosing a product

  • All three yellow lenses attenuated by more than half the short-wavelength blue range common in the simulated LED headlight spectrum.
  • Three commercial yellow lenses were compared with a clear lens under glare-on and glare-off conditions.
  • No duplicate verdict or reuse of this PMID or DOI was found.
Gap Measurement · Verdict 2517 · D 30
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

This was not a parallel randomized clinical trial; each person repeatedly experienced lens conditions in a single-center experiment. Twelve younger participants completed the navy-shirt condition, while separate groups of six younger and four older participants completed the orange-shirt condition. The sample of 22 is a design limitation, and the reported omnibus F test did not provide a treatment-effect confidence interval capable of precisely excluding benefit. There was no trial registration.

02

Why this is classified as D (30)

Pedestrian response time was a simulator measure rather than an actual crash outcome, and the sole publicly funded study included only 22 people. The lens effect was null without a confidence interval that could precisely exclude benefit. Public funding is reflected in D with 30 points.

Counterpoint. Glare itself delayed responses, especially among older participants. The issue is not whether glare matters, but whether yellow lenses solve it; they did not here.

Rejudgment record. Cross-check applied — We cross-checked participant groups, repeated lens conditions, the main outcome and F tests, spectral transmission, and NIH support against the primary paper.

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Yellow lenses speed nighttime pedestrian detection.DThe overall lens effect among 22 participants was null. Short-wavelength attenuation is recorded separately as a physical fact in product_facts.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Single-center repeated-measures night-driving simulator experiment4NIH grants R01EY024075 and P30EY003790Time from pedestrian appearance to horn responseOverall lens main effect F(1,63)=0.64, P=.42; yellow lenses were not faster than clear lenses in any conditionOnly small human experiment directly measuring the marketed performance claim
Study 2Spectral transmission and emission characterization of three products and the LED source3NIH grants R01EY024075 and P30EY003790Transmission in the short-wavelength blue rangeAll three yellow lenses attenuated more than half of the simulated LED headlight's short-wavelength rangeDirect measurement supporting the accepted optical fact
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-14).

Hwang AD, Tuccar-Burak M, Peli E. Comparison of Pedestrian Detection With and Without Yellow-Lens Glasses During Simulated Night Driving With and Without Headlight Glare. JAMA Ophthalmol. 2019;137(10):1147-1153. PMID: 31369054. PMCID: PMC6681548. DOI: 10.1001/jamaophthalmol.2019.2893.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-14 · Corrections: none

Cite this verdict

Yellow night-driving glasses x improved pedestrian detection Evidence Grade D card
[Chamgap] Yellow night-driving glasses x improved pedestrian detection — Evidence Grade D·30. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/eye/yellow-lens-night-driving-glasses-pedestrian-detection/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.